[New - The 5 SVB Critical Questions And Answers For Biotech](https://wbbsec.com/opinions-and-features/)
[New - The 5 SVB Critical Questions And Answers For Biotech](https://wbbsec.com/opinions-and-features/)
powered by bulletin
In: Press Releases

For Immediate Release

March 17, 2022

Cranford, NJ –  WBB Securities and the WBB Research Institute will sponsor a Demy-Colton Virtual Salon, beginning at 11:00 am EDT on March 17, 2022.  The Salon will feature three of the authors of a new, definitive report on the future of COVID, titled Getting to the Next Normal: A Roadmap for Living with COVID.  Participants will discuss the future evolution of the SARS-CoV-2 virus and how our society will need to adapt to COVID to achieve a more normal lifestyle.

Program participants include:  Dr. Ezekiel J. Emanuel, MD, PhD, Vice Provost for Global Initiatives and University Professor at the University of Pennsylvania, Dr. Rick A. Bright, PhD, CEO of the Pandemic Prevention Institute, and Dr. Michael T. Osterholm, PhD, MPH, Director of the Center for Infectious Disease Research and Policy at the University of Minnesota, along with Sheryl Gay Stolberg, Washington Correspondent at The New York Times covering healthcare.

Register and Join here: Getting to the Next Normal:  A Roadmap for Living with Covid

About WBB Research Institute.

WBB Research Institute is an independent, non-partisan, public policy institute, sponsored by WBB Securities.  We conduct research and offer commentary on healthcare issues through diverse information sources, including one-on-one meetings, seminars and written research, both to inform about and to comment on practices that could improve people’s health and quality of life.


About WBB Securities.

WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused primarily in the life sciences niche. Established in 2001 with offices in New Jersey, New York, and California. WBB Securities is registered with the SEC as a broker-dealer, a member of FINRA, and a state-registered investment advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients.


About Demy-Colton.

Demy Colton is a leader in biotech and life science events, with over 20 years’ experience connecting leaders of innovative biotech companies with key stakeholders, investors and advisors, we create ideal environments to examine and address opportunities and challenges in today’s biotech industry.